{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:28:39Z","timestamp":1791250119611,"version":"4.1.0"},"reference-count":317,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1378\/chest.125.1_suppl.1s","type":"journal-article","created":{"date-parts":[[2004,1,12]],"date-time":"2004-01-12T20:05:25Z","timestamp":1073937925000},"page":"1S-39S","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":469,"special_numbering":"S","title":["Cystic Fibrosis Adult Care"],"prefix":"10.1016","volume":"125","author":[{"given":"James R.","family":"Yankaskas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce C.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Sufian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.125.1_suppl.1S_bib1","series-title":"Clinical practice guidelines for cystic fibrosis","author":"Cystic Fibrosis Foundation","year":"1997"},{"key":"10.1378\/chest.125.1_suppl.1S_bib2","series-title":"Patient registry 2000 annual data report","author":"Cystic Fibrosis Foundation","year":"2001"},{"key":"10.1378\/chest.125.1_suppl.1S_bib3","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/thx.46.12.881","article-title":"Cystic fibrosis: current survival and population estimates to the year 2000","volume":"46","author":"Elborn","year":"1991","journal-title":"Thorax"},{"key":"10.1378\/chest.125.1_suppl.1S_bib4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJM199809033391002","article-title":"Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis","volume":"339","author":"Cohn","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM199809033391001","article-title":"Mutations of the cystic fibrosis gene in patients with chronic pancreatitis","volume":"339","author":"Sharer","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib6","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1001\/jama.284.14.1814","article-title":"Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population","volume":"284","author":"Wang","year":"2000","journal-title":"JAMA"},{"key":"10.1378\/chest.125.1_suppl.1S_bib7","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1001\/jama.1992.03480130110034","article-title":"Congenital bilateral absence of the vas deferens: a primarily genital form of cystic fibrosis","volume":"267","author":"Anguiano","year":"1992","journal-title":"JAMA"},{"key":"10.1378\/chest.125.1_suppl.1S_bib8","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJM199506013322204","article-title":"Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens","volume":"332","author":"Chillon","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib9","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.281.23.2217","article-title":"Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia","volume":"281","author":"Mak","year":"1999","journal-title":"JAMA"},{"key":"10.1378\/chest.125.1_suppl.1S_bib10","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/oxfordjournals.aje.a009172","article-title":"Gender gap in cystic fibrosis mortality","volume":"145","author":"Rosenfeld","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib11","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/thx.50.12.1301","article-title":"Genetic and clinical features of patients with cystic fibrosis diagnosed after the age of 16 years","volume":"50","author":"Gan","year":"1995","journal-title":"Thorax"},{"key":"10.1378\/chest.125.1_suppl.1S_bib12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1378\/chest.118.2.427","article-title":"Health status and sociodemographic characteristics of adults receiving a cystic fibrosis diagnosis after age 18 years","volume":"118","author":"Widerman","year":"2000","journal-title":"Chest"},{"key":"10.1378\/chest.125.1_suppl.1S_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0140-6736(93)91885-P","article-title":"Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849 + 10 kb C\u2192T mutation","volume":"342","author":"Augarten","year":"1993","journal-title":"Lancet"},{"key":"10.1378\/chest.125.1_suppl.1S_bib14","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJM199112053252307","article-title":"Cystic fibrosis gene mutation in two sisters with mild disease and normal sweat electrolyte levels","volume":"325","author":"Strong","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib15","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM199410133311503","article-title":"A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations","volume":"331","author":"Highsmith","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-3476(98)70344-0","article-title":"The diagnosis of cystic fibrosis: a consensus statement; Cystic Fibrosis Foundation Consensus Panel","volume":"132","author":"Rosenstein","year":"1998","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib17","series-title":"Sweat testing: sample collection and quantitative analysis; approved guideline","author":"National Committee for Clinical Laboratory Standards","year":"1994"},{"key":"10.1378\/chest.125.1_suppl.1S_bib18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1089\/hum.1995.6.4-445","article-title":"In vivonasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis","volume":"6","author":"Knowles","year":"1995","journal-title":"Hum Gene Ther"},{"key":"10.1378\/chest.125.1_suppl.1S_bib19","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-3476(98)70345-2","article-title":"Uncertainty in the diagnosis of cystic fibrosis: possible role ofin vivonasal potential difference measurements","volume":"132","author":"Wilson","year":"1998","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib20","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/oxfordjournals.aje.a008664","article-title":"Determinants of mortality from cystic fibrosis in Canada, 1970\u20131989","volume":"143","author":"Corey","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/(SICI)1099-0496(199605)21:5<267::AID-PPUL1>3.0.CO;2-K","article-title":"Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis","volume":"21","author":"Armstrong","year":"1996","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1164\/ajrccm\/144.2.331","article-title":"Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients","volume":"144","author":"Ramsey","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.125.1_suppl.1S_bib23","series-title":"Consensus conference: microbiology and infectious diseases in cystic fibrosis.","first-page":"1","author":"Cystic Fibrosis Foundation","year":"1994"},{"key":"10.1378\/chest.125.1_suppl.1S_bib24","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1086\/514631","article-title":"Microbiology of sputum from patients at cystic fibrosis centers in the United States","volume":"27","author":"Burns","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.125.1_suppl.1S_bib25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/clinids\/23.3.532","article-title":"Antibiotic susceptibility of multiply resistantPseudomonas aeruginosaisolated from patients with cystic fibrosis, including candidates for transplantation","volume":"23","author":"Saiman","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.125.1_suppl.1S_bib26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1164\/ajrccm.164.1.2011153","article-title":"Disproportionate distribution ofBurkholderia cepaciacomplex species and transmissibility markers in cystic fibrosis","volume":"164","author":"LiPuma","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1542\/peds.63.1.24","article-title":"The chest roentgenogram in cystic fibrosis: a new scoring system","volume":"63","author":"Brasfield","year":"1979","journal-title":"Pediatrics"},{"key":"10.1378\/chest.125.1_suppl.1S_bib28","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1542\/peds.91.2.488","article-title":"Wisconsin cystic fibrosis chest radiograph scoring system","volume":"91","author":"Weatherly","year":"1993","journal-title":"Pediatrics"},{"key":"10.1378\/chest.125.1_suppl.1S_bib29","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1164\/ajrccm.154.5.8912731","article-title":"Cystic fibrosis","volume":"154","author":"Davis","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0272-5231(05)70095-2","article-title":"Basic therapies in cystic fibrosis: does standard therapy work?","volume":"19","author":"Marshall","year":"1998","journal-title":"Clin Chest Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1056\/NEJM199607183350307","article-title":"Management of pulmonary disease in patients with cystic fibrosis","volume":"335","author":"Ramsey","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib32","series-title":"Cystic fibrosis in adults","year":"1999"},{"key":"10.1378\/chest.125.1_suppl.1S_bib33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2165\/00003088-198713040-00002","article-title":"Antibiotic pharmacokinetics in cystic fibrosis: differences and clinical significance","volume":"13","author":"de Groot","year":"1987","journal-title":"Clin Pharmacokinet"},{"key":"10.1378\/chest.125.1_suppl.1S_bib34","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/0140-6736(90)92571-X","article-title":"Person-to-person spread ofPseudomonas cepaciabetween patients with cystic fibrosis","volume":"336","author":"LiPuma","year":"1996","journal-title":"Lancet"},{"key":"10.1378\/chest.125.1_suppl.1S_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled tobramycin in patients with cystic fibrosis","volume":"340","author":"Ramsey","year":"1999","journal-title":"N Engl J Med"},{"issue":"Suppl 19","key":"10.1378\/chest.125.1_suppl.1S_bib36","first-page":"243","article-title":"Safety and effectiveness of 2 years of treatment with intermittent inhaled tobramycin in CF patients [abstract]","author":"Nickerson","year":"1999","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib37","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0140-6736(81)90588-2","article-title":"Aerosol carbenicillin and gentamicin treatment ofPseudomonas aeruginosainfection in patients with cystic fibrosis","volume":"2","author":"Hodson","year":"1981","journal-title":"Lancet"},{"key":"10.1378\/chest.125.1_suppl.1S_bib38","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0140-6736(83)92428-5","article-title":"Inhaled antibiotics in cystic fibrosis [letter]","volume":"1","author":"Wall","year":"1983","journal-title":"Lancet"},{"key":"10.1378\/chest.125.1_suppl.1S_bib39","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0007-0971(87)90184-7","article-title":"A controlled trial of nebulized aminoglycoside and oral flucloxacillin versus placebo in the outpatient management of children with cystic fibrosis","volume":"81","author":"Carswell","year":"1987","journal-title":"Br J Dis Chest"},{"key":"10.1378\/chest.125.1_suppl.1S_bib40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.1950060207","article-title":"Long-term tobramycin aerosol therapy in cystic fibrosis","volume":"6","author":"Steinkamp","year":"1989","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib41","first-page":"43","article-title":"Nebulized gentamicin in children and adolescents with cystic fibrosis","volume":"20","author":"Kun","year":"1984","journal-title":"Aust Paediatr J"},{"key":"10.1378\/chest.125.1_suppl.1S_bib42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ppul.1950070110","article-title":"Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized withPseudomonas aeruginosa.","volume":"7","author":"MacLusky","year":"1989","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib43","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/jac\/19.6.831","article-title":"Colistin inhalation therapy in cystic fibrosis patients with chronicPseudomonas aeruginosalung infection","volume":"19","author":"Jensen","year":"1987","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.125.1_suppl.1S_bib44","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(85)92222-6","article-title":"Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis [letter]","volume":"1","author":"Littlewood","year":"1985","journal-title":"Lancet"},{"key":"10.1378\/chest.125.1_suppl.1S_bib45","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ppul.10166","article-title":"Transmission of colistin-resistantPseudomonas aeruginosabetween patients attending a pediatric cystic fibrosis center","volume":"34","author":"Denton","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib46","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1136\/adc.84.5.432","article-title":"Bronchoconstriction following nebulised colistin in cystic fibrosis","volume":"84","author":"Cunningham","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1378\/chest.125.1_suppl.1S_bib47","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1183\/09031936.02.00248102","article-title":"A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis","volume":"20","author":"Hodson","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.125.1_suppl.1S_bib48","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1651-2227.1983.tb09789.x","article-title":"Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronicPseudomonas aeruginosainfection","volume":"72","author":"Szaff","year":"1983","journal-title":"Acta Paediatr Scand"},{"key":"10.1378\/chest.125.1_suppl.1S_bib49","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/thorax.55.5.355","article-title":"Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs","volume":"55","author":"Elborn","year":"2000","journal-title":"Thorax"},{"key":"10.1378\/chest.125.1_suppl.1S_bib50","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1164\/ajrccm.157.6.9710075","article-title":"Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin","volume":"157","author":"Kudoh","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib51","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(05)78360-4","article-title":"Long-term azithromycin may improve lung function in children with cystic fibrosis [letter]","volume":"351","author":"Jaffe","year":"1998","journal-title":"Lancet"},{"issue":"Suppl 19","key":"10.1378\/chest.125.1_suppl.1S_bib52","first-page":"283","article-title":"Effect of chronic azithromycin on lung function in cystic fibrosis [abstract]","author":"Anstead","year":"1999","journal-title":"Pediatr Pulmonol"},{"issue":"Suppl 19","key":"10.1378\/chest.125.1_suppl.1S_bib53","first-page":"263","article-title":"Long term macrolide antibiotics improve pulmonary function in cystic fibrosis [abstract]","author":"Pirzada","year":"1999","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib54","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(02)11081-6","article-title":"Long term azithromycin in children with cystic fibrosis: a randomized, placebo-controlled crossover trial","volume":"360","author":"Equi","year":"2002","journal-title":"Lancet"},{"key":"10.1378\/chest.125.1_suppl.1S_bib55","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/thorax.57.3.212","article-title":"Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial","volume":"57","author":"Wolter","year":"2002","journal-title":"Thorax"},{"key":"10.1378\/chest.125.1_suppl.1S_bib56","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","article-title":"A multicenter, randomized, placebo controlled, double-blind trial of azithromycin in patients with cystic fibrosis chronically infected withPseudomonas aeruginosa.","volume":"290","author":"Saiman","year":"2003","journal-title":"JAMA"},{"key":"10.1378\/chest.125.1_suppl.1S_bib57","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0022-3476(83)80579-4","article-title":"Immediate and long-term effects of chest physiotherapy in patients with cystic fibrosis","volume":"103","author":"Desmond","year":"1983","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib58","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0022-3476(88)80370-6","article-title":"Role of conventional physiotherapy in cystic fibrosis","volume":"113","author":"Reisman","year":"1988","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib59","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/thx.45.1.77","article-title":"Effect of chest physiotherapy on oxygen saturation in patients with cystic fibrosis","volume":"45","author":"Pryor","year":"1990","journal-title":"Thorax"},{"key":"10.1378\/chest.125.1_suppl.1S_bib60","first-page":"23","article-title":"Esophageal pH monitoring data during chest physiotherapy","volume":"13","author":"Vandenplas","year":"1991","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib61","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/thx.49.2.115","article-title":"Treatment compliance in adults with cystic fibrosis","volume":"49","author":"Abbott","year":"1994","journal-title":"Thorax"},{"key":"10.1378\/chest.125.1_suppl.1S_bib62","first-page":"323","article-title":"Noninvasive clearance of airway secretions","volume":"2","author":"Hardy","year":"1996","journal-title":"Respir Care Clin N Am"},{"key":"10.1378\/chest.125.1_suppl.1S_bib63","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1164\/ajrccm\/151.3_Pt_1.846","article-title":"Chest physical therapy management of patients with cystic fibrosis: a meta-analysis","volume":"151","author":"Thomas","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib64","first-page":"1218","article-title":"Positive expiratory pressure mask therapy: theoretical and practical considerations and a review of the literature","volume":"36","author":"Mahlmeister","year":"1991","journal-title":"Respir Care"},{"key":"10.1378\/chest.125.1_suppl.1S_bib65","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0022-3476(97)70064-7","article-title":"Long-term comparative trial of conventional postural drainage and percussion versus positive expiratory pressure physiotherapy in the treatment of cystic fibrosis","volume":"131","author":"McIlwaine","year":"1997","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib66","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1067\/mpd.2001.114017","article-title":"Long-term comparative trial of positive expiratory pressure versus oscillating positive expiratory pressure (flutter) physiotherapy in the treatment of cystic fibrosis","volume":"138","author":"McIlwaine","year":"2001","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib67","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1164\/ajrccm.150.4.7921452","article-title":"Comparison of high frequency chest compression and conventional chest physiotherapy in hospitalized patients with cystic fibrosis","volume":"150","author":"Arens","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib68","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0140-6736(81)91440-9","article-title":"Effect of swimming on forced expiration and sputum clearance in cystic fibrosis","volume":"2","author":"Zach","year":"1981","journal-title":"Lancet"},{"key":"10.1378\/chest.125.1_suppl.1S_bib69","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/ptj\/69.8.633","article-title":"Relative effects of bronchial drainage and exercise for in-hospital care of patients with cystic fibrosis","volume":"69","author":"Cerny","year":"1989","journal-title":"Phys Ther"},{"key":"10.1378\/chest.125.1_suppl.1S_bib70","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1651-2227.1987.tb10417.x","article-title":"Long-term effects of physical exercise on working capacity and pulmonary function in cystic fibrosis","volume":"76","author":"Andreasson","year":"1987","journal-title":"Acta Paediatr Scand"},{"key":"10.1378\/chest.125.1_suppl.1S_bib71","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1067\/mpd.2000.103408","article-title":"A randomized controlled trial of a 3-year home exercise program in cystic fibrosis","volume":"136","author":"Schneiderman-Walker","year":"2000","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib72","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199212173272504","article-title":"The prognostic value of exercise testing in patients with cystic fibrosis","volume":"327","author":"Nixon","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib73","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1164\/arrd.1984.129.5.708","article-title":"Oxygen saturation during exercise in cystic fibrosis","volume":"129","author":"Henke","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.125.1_suppl.1S_bib74","doi-asserted-by":"crossref","first-page":"9188","DOI":"10.1073\/pnas.87.23.9188","article-title":"Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum","volume":"87","author":"Shak","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1378\/chest.125.1_suppl.1S_bib75","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis: the Pulmozyme Study Group","volume":"331","author":"Fuchs","year":"1994","journal-title":"N Engl J Med"},{"issue":"Suppl 10","key":"10.1378\/chest.125.1_suppl.1S_bib76","first-page":"113","article-title":"Long-term follow-up of phase III rhDNase trial [abstract]","author":"Rosenstein","year":"1994","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib77","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1378\/chest.110.4.889","article-title":"Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease: Pulmozyme Study Group","volume":"110","author":"McCoy","year":"1996","journal-title":"Chest"},{"key":"10.1378\/chest.125.1_suppl.1S_bib78","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1067\/mpd.2001.118570","article-title":"A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities","volume":"139","author":"Quan","year":"2001","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib79","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1183\/09031936.96.09030531","article-title":"The effects of recombinant human DNase on neutrophil elastase activity and interleukin-8 levels in the sputum of patients with cystic fibrosis","volume":"9","author":"Shah","year":"1996","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.125.1_suppl.1S_bib80","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1164\/ajrccm.153.6.8665055","article-title":"Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations","volume":"153","author":"Wilmott","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib81","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1378\/chest.49.4.370","article-title":"Acute effects of aerosolized acetylcysteine upon spirometric measures in subjects with and without obstructive pulmonary disease [letter]","volume":"49","author":"Moser","year":"1966","journal-title":"Dis Chest"},{"key":"10.1378\/chest.125.1_suppl.1S_bib82","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0954-6111(06)80220-9","article-title":"N-acetylcysteine by metered dose inhaler in the treatment of chronic bronchitis: a multi-centre study","volume":"86","author":"Dueholm","year":"1992","journal-title":"Respir Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib83","first-page":"17","article-title":"Acute effects of nebulization of n-acetylcysteine on pulmonary mechanics and gas exchange","volume":"102","author":"Rao","year":"1970","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.125.1_suppl.1S_bib84","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1183\/09031936.93.02030234","article-title":"N-acetylcysteine in cystic fibrosis andPseudomonas aeruginosainfection: clinical score, spirometry and ciliary motility","volume":"2","author":"Stafanger","year":"1989","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.125.1_suppl.1S_bib85","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF00441781","article-title":"A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis","volume":"144","author":"Ratjen","year":"1985","journal-title":"Eur J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib86","first-page":"73","article-title":"No penetration of orally administered N-acetylcysteine into bronchoalveolar lavage fluid","volume":"70","author":"Cotgreave","year":"1987","journal-title":"Eur J Respir Dis"},{"key":"10.1378\/chest.125.1_suppl.1S_bib87","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/thx.52.10.900","article-title":"Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis","volume":"52","author":"Robinson","year":"1997","journal-title":"Thorax"},{"key":"10.1378\/chest.125.1_suppl.1S_bib88","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1164\/ajrccm.156.1.9512074","article-title":"Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I","volume":"156","author":"King","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib89","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1172\/JCI119138","article-title":"Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea","volume":"99","author":"Wills","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.125.1_suppl.1S_bib90","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/(SICI)1099-0496(199602)21:2<77::AID-PPUL3>3.0.CO;2-M","article-title":"Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis","volume":"21","author":"Eng","year":"1996","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib91","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/(SICI)1099-0496(199605)21:5<282::AID-PPUL3>3.0.CO;2-P","article-title":"Airway responsiveness to hyperosmolar saline challenge in cystic fibrosis: a pilot study","volume":"21","author":"Rodwell","year":"1996","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib92","first-page":"889","article-title":"A longitudinal study of bronchodilator responsiveness in cystic fibrosis","volume":"131","author":"Hordvik","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.125.1_suppl.1S_bib93","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ppul.1950200402","article-title":"Short-term and long-term effects of albuterol aerosol therapy in cystic fibrosis: a preliminary report","volume":"20","author":"Konig","year":"1995","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib94","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/(SICI)1099-0496(199801)25:1<32::AID-PPUL3>3.0.CO;2-Q","article-title":"A placebo-controlled, double blind trial of the long-term effects of albuterol administration in patients with cystic fibrosis","volume":"25","author":"Konig","year":"1998","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib95","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1164\/ajrccm.154.1.8680672","article-title":"The effects of albuterol on the lung function of hospitalized patients with cystic fibrosis","volume":"154","author":"Hordvik","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib96","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1378\/chest.99.5.1088","article-title":"A controlled trial of long-term bronchodilator therapy in cystic fibrosis","volume":"99","author":"Eggleston","year":"1991","journal-title":"Chest"},{"key":"10.1378\/chest.125.1_suppl.1S_bib97","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1164\/arrd.1985.131.4.537","article-title":"Bronchodilators increase airway instability in cystic fibrosis","volume":"131","author":"Zach","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.125.1_suppl.1S_bib98","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/(SICI)1099-0496(199901)27:1<43::AID-PPUL9>3.0.CO;2-E","article-title":"Effects of standard and high doses of salmeterol on lung function of hospitalized patients with cystic fibrosis","volume":"27","author":"Hordvik","year":"1999","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib99","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ppul.10117","article-title":"Effects of salmeterol on arterial oxyhemoglobin saturations in patients with cystic fibrosis","volume":"34","author":"Salvatore","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ppul.10162","article-title":"Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis","volume":"34","author":"Hordvik","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib101","series-title":"Textbook of respiratory medicine","first-page":"289","article-title":"Airway pharmacology","author":"Barnes","year":"1994"},{"key":"10.1378\/chest.125.1_suppl.1S_bib102","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1378\/chest.97.2.425","article-title":"Nebulized ipratropium in the treatment of acute asthma","volume":"97","author":"Summers","year":"1990","journal-title":"Chest"},{"key":"10.1378\/chest.125.1_suppl.1S_bib103","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1378\/chest.95.4.861","article-title":"The inhaled bronchodilators ipratropium bromide and metaproterenol in adults with CF","volume":"95","author":"Weintraub","year":"1989","journal-title":"Chest"},{"key":"10.1378\/chest.125.1_suppl.1S_bib104","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0022-3476(05)80927-8","article-title":"Acute bronchodilator response to a combination of beta-adrenergic and anticholinergic agents in patients with cystic fibrosis","volume":"120","author":"Sanchez","year":"1992","journal-title":"J Pediatr"},{"issue":"suppl","key":"10.1378\/chest.125.1_suppl.1S_bib105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1164\/ajrccm\/147.6_Pt_2.S40","article-title":"Review of the clinical efficacy of theophylline in the treatment of chronic obstructive pulmonary disease","volume":"147","author":"Vaz Fragoso","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.125.1_suppl.1S_bib106","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/thx.41.1.34","article-title":"Prednisolone in the treatment of airflow obstruction in adults with cystic fibrosis","volume":"41","author":"Pantin","year":"1986","journal-title":"Thorax"},{"key":"10.1378\/chest.125.1_suppl.1S_bib107","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/adc.71.1.35","article-title":"Interleukin-1 alpha, soluble interleukin-2 receptor, and IgG concentrations in cystic fibrosis treated with prednisolone","volume":"71","author":"Greally","year":"1994","journal-title":"Arch Dis Child"},{"key":"10.1378\/chest.125.1_suppl.1S_bib108","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0140-6736(85)92929-0","article-title":"Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis","volume":"2","author":"Auerbach","year":"1985","journal-title":"Lancet"},{"key":"10.1378\/chest.125.1_suppl.1S_bib109","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1542\/peds.87.2.245","article-title":"Risks of alternate-day prednisone in patients with cystic fibrosis","volume":"87","author":"Rosenstein","year":"1991","journal-title":"Pediatrics"},{"key":"10.1378\/chest.125.1_suppl.1S_bib110","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0022-3476(95)70343-8","article-title":"A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis: Cystic Fibrosis Foundation Prednisone Trial Group","volume":"126","author":"Eigen","year":"1995","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib111","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJM200003233421204","article-title":"Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis","volume":"342","author":"Lai","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib112","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1651-2227.1983.tb09712.x","volume":"72","author":"Schiotz","year":"1983","journal-title":"Acta Paediatr Scand"},{"key":"10.1378\/chest.125.1_suppl.1S_bib113","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0954-6111(95)90249-X","article-title":"The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis","volume":"89","author":"van Haren","year":"1995","journal-title":"Respir Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib114","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0022-3476(96)70407-9","article-title":"Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis","volume":"128","author":"Nikolaizik","year":"1996","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib115","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJM199503303321303","article-title":"Effect of high-dose ibuprofen in patients with cystic fibrosis","volume":"332","author":"Konstan","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib116","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/archpedi.1980.02130150025007","article-title":"Heart failure in cystic fibrosis: treatment and prognosis of cor pulmonale with failure of the right side of the heart","volume":"134","author":"Stern","year":"1980","journal-title":"Am J Dis Child"},{"key":"10.1378\/chest.125.1_suppl.1S_bib117","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1378\/chest.115.5.1321","article-title":"Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia","volume":"115","author":"Fraser","year":"1999","journal-title":"Chest"},{"key":"10.1378\/chest.125.1_suppl.1S_bib118","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0022-3476(89)80553-0","article-title":"Nocturnal home oxygen in the treatment of hypoxemic cystic fibrosis patients","volume":"114","author":"Zinman","year":"1989","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib119","doi-asserted-by":"crossref","first-page":"391","DOI":"10.7326\/0003-4819-93-3-391","article-title":"Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease","volume":"93","author":"Nocturnal Oxygen Therapy Trial Group","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib120","first-page":"681","article-title":"Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema","volume":"1","author":"Medical Research Council Working Party","year":"1981","journal-title":"Lancet"},{"key":"10.1378\/chest.125.1_suppl.1S_bib121","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1378\/chest.84.4.388","article-title":"Ventilation and oxygenation changes during sleep in cystic fibrosis","volume":"84","author":"Tepper","year":"1983","journal-title":"Chest"},{"key":"10.1378\/chest.125.1_suppl.1S_bib122","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1378\/chest.116.3.647","article-title":"Hypoxemia and hypercapnia during exercise and sleep in patients with cystic fibrosis","volume":"116","author":"Bradley","year":"1999","journal-title":"Chest"},{"key":"10.1378\/chest.125.1_suppl.1S_bib123","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1378\/chest.119.2.434","article-title":"Predictability of oxygen desaturation during sleep in patients with cystic fibrosis: clinical, spirometric, and exercise parameters","volume":"119","author":"Frangolias","year":"2001","journal-title":"Chest"},{"key":"10.1378\/chest.125.1_suppl.1S_bib124","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ppul.1950150311","article-title":"Cystic Fibrosis Foundation consensus conference report on pulmonary complications of cystic fibrosis","volume":"15","author":"Schidlow","year":"1993","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib125","series-title":"Pediatric gastrointestinal disease","first-page":"1466","article-title":"Cystic fibrosis","author":"Forstner","year":"1996"},{"key":"10.1378\/chest.125.1_suppl.1S_bib126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0016-5085(84)90582-1","article-title":"Colipase and lipase secretion in childhood-onset pancreatic insufficiency: delineation of patients with steatorrhea secondary to relative colipase deficiency","volume":"86","author":"Gaskin","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1378\/chest.125.1_suppl.1S_bib127","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0022-3476(73)80220-3","article-title":"Fecal chymotrypsin: a reliable index of exocrine pancreatic function in children","volume":"83","author":"Bonin","year":"1973","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib128","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-3476(85)80510-2","article-title":"Age-related alterations in immunoreactive pancreatic lipase and cationic trypsinogen in young children with cystic fibrosis","volume":"107","author":"Cleghorn","year":"1985","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib129","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/(SICI)1099-0496(200003)29:3<172::AID-PPUL3>3.0.CO;2-1","article-title":"Evaluation of fecal pancreatic elastase-1 as a measure of pancreatic exocrine function in children with cystic fibrosis","volume":"29","author":"Cade","year":"2000","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib130","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1067\/mpd.2002.124829","article-title":"How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease?","volume":"141","author":"Beharry","year":"2002","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib131","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1001\/jama.1990.03440180065033","article-title":"Treatment failure after substitution of generic pancrelipase capsules: correlation with in vitro lipase activity","volume":"263","author":"Hendeles","year":"1990","journal-title":"JAMA"},{"key":"10.1378\/chest.125.1_suppl.1S_bib132","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/j.1552-4604.1994.tb03981.x","article-title":"Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis andin vitroperformance of microencapsulated formulations","volume":"34","author":"Kraisinger","year":"1994","journal-title":"J Clin Pharmacol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib133","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/ajcn\/55.1.108","article-title":"Nutritional assessment and management in cystic fibrosis: a consensus report: the Consensus Committee","volume":"55","author":"Ramsey","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib134","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJM199705013361803","article-title":"High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis","volume":"336","author":"FitzSimmons","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib135","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0022-3476(95)70113-3","article-title":"Cystic fibrosis-associated colitis and fibrosing colonopathy","volume":"127","author":"Schwarzenberg","year":"1995","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib136","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(95)91860-4","article-title":"Fibrosing colonopathy in cystic fibrosis: results of a case-control study","volume":"346","author":"Smyth","year":"1995","journal-title":"Lancet"},{"key":"10.1378\/chest.125.1_suppl.1S_bib137","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/BF01536673","article-title":"Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis","volume":"33","author":"Dutta","year":"1988","journal-title":"Dig Dis Sci"},{"key":"10.1378\/chest.125.1_suppl.1S_bib138","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/gut.21.9.778","article-title":"Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis","volume":"21","author":"Durie","year":"1980","journal-title":"Gut"},{"key":"10.1378\/chest.125.1_suppl.1S_bib139","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-114-3-200","article-title":"Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis","volume":"114","author":"Heijerman","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib140","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0022-3476(95)70153-2","article-title":"Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy: Consensus Committee","volume":"127","author":"Borowitz","year":"1995","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib141","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1651-2227.1978.tb16273.x","article-title":"Relative underweight in cystic fibrosis and its prognostic value","volume":"67","author":"Kraemer","year":"1978","journal-title":"Acta Paediatr Scand"},{"key":"10.1378\/chest.125.1_suppl.1S_bib142","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0002-9343(87)90147-1","article-title":"Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis","volume":"82","author":"Huang","year":"1987","journal-title":"Am J Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib143","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0895-4356(88)90063-7","article-title":"A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto","volume":"41","author":"Corey","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib144","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/aje\/153.4.345","article-title":"Predictive 5-year survivorship model of cystic fibrosis","volume":"153","author":"Liou","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib145","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/0002-8223(94)90095-7","article-title":"Lipid levels in adults with cystic fibrosis","volume":"94","author":"Slesinski","year":"1994","journal-title":"J Am Diet Assoc"},{"key":"10.1378\/chest.125.1_suppl.1S_bib146","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","author":"National Cholesterol Education Program","year":"2001","journal-title":"JAMA"},{"key":"10.1378\/chest.125.1_suppl.1S_bib147","first-page":"2","volume":"64","author":"Metropolitan Life Insurance Company","year":"1983","journal-title":"Statistical Bulletin"},{"key":"10.1378\/chest.125.1_suppl.1S_bib148","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0261-5614(98)80061-7","article-title":"Nutrition in adults with cystic fibrosis","volume":"17","author":"Bell","year":"1998","journal-title":"Clin Nutr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib149","first-page":"141","article-title":"Nutritional rehabilitation in cystic fibrosis: a 5-year follow-up study","volume":"15","author":"Dalzell","year":"1992","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib150","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0022-3476(94)70312-4","article-title":"Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis","volume":"124","author":"Steinkamp","year":"1994","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib151","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/gut.44.1.87","article-title":"Percutaneous endoscopic gastrostomy feeding in patients with cystic fibrosis","volume":"44","author":"Williams","year":"1999","journal-title":"Gut"},{"key":"10.1378\/chest.125.1_suppl.1S_bib152","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0022-3476(98)70443-3","article-title":"Enteral nutrition for patients with cystic fibrosis: comparison of a semi-elemental and nonelemental formula","volume":"132","author":"Erskine","year":"1998","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib153","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/011542659501000273","article-title":"Prolonged parenteral nutrition for cystic fibrosis patients","volume":"10","author":"Allen","year":"1995","journal-title":"Nutr Clin Pract"},{"key":"10.1378\/chest.125.1_suppl.1S_bib154","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1067\/mpd.2001.113633","article-title":"Treatment of vitamin K deficiency in cystic fibrosis: effectiveness of a daily fat-soluble vitamin combination","volume":"138","author":"Wilson","year":"2001","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0168-8227(99)00058-3","article-title":"Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report","volume":"45","author":"Moran","year":"1999","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1378\/chest.125.1_suppl.1S_bib156","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0022-3476(98)70171-4","article-title":"Abnormal glucose metabolism in cystic fibrosis","volume":"133","author":"Moran","year":"1998","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib157","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0022-3476(88)80315-9","article-title":"Diabetes mellitus associated with cystic fibrosis","volume":"112","author":"Finkelstein","year":"1988","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib158","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/BF01957574","article-title":"Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis","volume":"151","author":"Lanng","year":"1992","journal-title":"Eur J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib159","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1651-2227.1994.tb13156.x","article-title":"Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections","volume":"83","author":"Lanng","year":"1994","journal-title":"Acta Paediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib160","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1164\/ajrccm.162.3.9904075","article-title":"Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline","volume":"162","author":"Milla","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib161","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1651-2227.1994.tb12956.x","article-title":"Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications","volume":"83","author":"Lanng","year":"1994","journal-title":"Acta Paediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib162","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00005792-198611000-00004","article-title":"The interaction of 2 diseases: diabetes mellitus and cystic fibrosis","volume":"65","author":"Rodman","year":"1986","journal-title":"Medicine (Baltimore)"},{"key":"10.1378\/chest.125.1_suppl.1S_bib163","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1542\/peds.84.4.642","article-title":"Diabetic microangiopathy in patients with cystic fibrosis","volume":"84","author":"Sullivan","year":"1989","journal-title":"Pediatrics"},{"issue":"Suppl 14","key":"10.1378\/chest.125.1_suppl.1S_bib164","first-page":"306","article-title":"Generalized atherosclerosis in an adult with CF and diabetes mellitus","author":"Schlesinger","year":"1997","journal-title":"[abstract] Pediatr Pulmonol"},{"issue":"Suppl 13","key":"10.1378\/chest.125.1_suppl.1S_bib165","first-page":"99","article-title":"A longitudinal study of the effects of pregnancy on 325 women with cystic fibrosis [abstract]","author":"FitzSimmons","year":"1996","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib166","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0020-7292(95)90312-7","article-title":"Diabetes and pregnancy. ACOG technical bulletin. Number 200-December 1994","volume":"48","author":"Committe on Technical Bulletins of the American College of Obstetricians and Gynecologists","year":"1995","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1378\/chest.125.1_suppl.1S_bib167","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM199511093331901","article-title":"Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy","volume":"333","author":"de Veciana","year":"1995","journal-title":"N Engl J Med"},{"issue":"suppl","key":"10.1378\/chest.125.1_suppl.1S_bib168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005176-199900001-00001","article-title":"Recommendations for management of liver and biliary tract disease in cystic fibrosis: Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group","volume":"28","author":"Sokol","year":"1999","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib169","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0022-3476(94)70361-2","article-title":"Analysis of risk factors for the development of liver disease associated with cystic fibrosis","volume":"124","author":"Colombo","year":"1994","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib170","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJM198802113180602","article-title":"Liver disease and common-bile-duct stenosis in cystic fibrosis","volume":"318","author":"Gaskin","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib171","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(89)92035-7","article-title":"Liver disease and bile duct abnormalities in adults with cystic fibrosis","volume":"2","author":"Nagel","year":"1989","journal-title":"Lancet"},{"key":"10.1378\/chest.125.1_suppl.1S_bib172","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1148\/radiographics.20.3.g00ma08767","article-title":"Hepatobiliary and pancreatic manifestations of cystic fibrosis: MR imaging appearances","volume":"20","author":"King","year":"2000","journal-title":"Radiographics"},{"key":"10.1378\/chest.125.1_suppl.1S_bib173","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","article-title":"Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis","volume":"113","author":"Poupon","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1378\/chest.125.1_suppl.1S_bib174","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(05)72401-6","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","volume":"355","author":"Lindor","year":"2000","journal-title":"Lancet"},{"key":"10.1378\/chest.125.1_suppl.1S_bib175","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/hep.1840160412","article-title":"Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study","volume":"16","author":"Colombo","year":"1992","journal-title":"Hepatology"},{"key":"10.1378\/chest.125.1_suppl.1S_bib176","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/0016-5085(93)90672-Y","article-title":"Hepatoprotective properties of ursodeoxycholic acid","volume":"104","author":"Heuman","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1378\/chest.125.1_suppl.1S_bib177","series-title":"Strategies for the treatment of hepatobiliary diseases","first-page":"13","article-title":"Bile acid hepatotoxicity and the rationale for UDCA therapy in chronic cholestatic liver disease: some hypotheses","author":"Hofmann","year":"1990"},{"key":"10.1378\/chest.125.1_suppl.1S_bib178","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0022-3565(25)24517-7","article-title":"Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection","volume":"272","author":"Botla","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1378\/chest.125.1_suppl.1S_bib179","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00004836-200104000-00009","article-title":"Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease","volume":"32","author":"Nousia-Arvanitakis","year":"2001","journal-title":"J Clin Gastroenterol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib180","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0022-3476(05)81103-5","article-title":"Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis","volume":"117","author":"Colombo","year":"1990","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib181","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0022-3476(05)82561-2","article-title":"Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis","volume":"121","author":"Galabert","year":"1992","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib182","first-page":"49","article-title":"Effect of ursodeoxycholic acid therapy on hepatic function in children with intrahepatic cholestatic liver disease","volume":"26","author":"Narkewicz","year":"1998","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib183","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0022-3476(97)70310-X","article-title":"Ursodeoxycholic acid improves the hepatic metabolism of essential fatty acids and retinol in children with cystic fibrosis","volume":"130","author":"Lepage","year":"1997","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib184","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/gut.31.8.918","article-title":"Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis","volume":"31","author":"Cotting","year":"1990","journal-title":"Gut"},{"key":"10.1378\/chest.125.1_suppl.1S_bib185","first-page":"198","article-title":"Effect of a medium dose of ursodeoxycholic acid with or without taurine supplementation on the nutritional status of patients with cystic fibrosis: a randomized, placebo-controlled, crossover trial","volume":"19","author":"Merli","year":"1994","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib186","first-page":"1484","article-title":"Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial; The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis","volume":"23","author":"Colombo","year":"1996","journal-title":"Hepatology"},{"key":"10.1378\/chest.125.1_suppl.1S_bib187","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/hep.510270126","article-title":"A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease","volume":"27","author":"Lindblad","year":"1998","journal-title":"Hepatology"},{"key":"10.1378\/chest.125.1_suppl.1S_bib188","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.1840150421","article-title":"Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease","volume":"15","author":"Colombo","year":"1992","journal-title":"Hepatology"},{"key":"10.1378\/chest.125.1_suppl.1S_bib189","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/00365529709007686","article-title":"Low-dose versus high-dose ursodeoxycholic acid in cystic fibrosis-related cholestatic liver disease: results of a randomized study with 1-year follow-up","volume":"32","author":"van de Meeberg","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib190","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0889-8553(21)00165-5","article-title":"Fat-soluble vitamins and their importance in patients with cholestatic liver diseases","volume":"23","author":"Sokol","year":"1994","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1378\/chest.125.1_suppl.1S_bib191","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0140-6736(90)91668-Z","article-title":"Meta-analysis of value of propranolol in prevention of variceal haemorrhage","volume":"336","author":"Hayes","year":"1990","journal-title":"Lancet"},{"key":"10.1378\/chest.125.1_suppl.1S_bib192","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/gast.1997.v112.pm9024301","article-title":"Primary prophylaxis of variceal bleeding in cirrhosis: a cost-effectiveness analysis","volume":"112","author":"Teran","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1378\/chest.125.1_suppl.1S_bib193","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0889-8553(21)00182-5","article-title":"Prevention of initial variceal hemorrhage","volume":"21","author":"Grace","year":"1992","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1378\/chest.125.1_suppl.1S_bib194","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1053\/jhep.2001.23054","article-title":"A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding","volume":"33","author":"Imperiale","year":"2001","journal-title":"Hepatology"},{"key":"10.1378\/chest.125.1_suppl.1S_bib195","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJM199904013401302","article-title":"Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding","volume":"340","author":"Sarin","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib196","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.2214\/ajr.159.6.1442401","article-title":"Transjugular intrahepatic portosystemic shunt in a child with cystic fibrosis","volume":"159","author":"Kerns","year":"1992","journal-title":"AJR Am J Roentgenol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib197","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0168-8278(99)80166-4","article-title":"Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension","volume":"31","author":"Debray","year":"1999","journal-title":"J Hepatol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib198","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0022-3476(95)70022-6","article-title":"Clinical denouement and mutation analysis of patients with cystic fibrosis undergoing liver transplantation for biliary cirrhosis","volume":"127","author":"Mack","year":"1995","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib199","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/adc.71.4.349","article-title":"Liver transplantation for hepatic cirrhosis in cystic fibrosis","volume":"71","author":"Noble-Jamieson","year":"1994","journal-title":"Arch Dis Child"},{"key":"10.1378\/chest.125.1_suppl.1S_bib200","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00006676-200105000-00010","article-title":"Gastrointestinal, liver, and pancreatic involvement in adult patients with cystic fibrosis","volume":"22","author":"Modolell","year":"2001","journal-title":"Pancreas"},{"key":"10.1378\/chest.125.1_suppl.1S_bib201","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1651-2227.1993.tb12754.x","article-title":"Failure of ursodeoxycholic acid to dissolve radiolucent gallstones in patients with cystic fibrosis","volume":"82","author":"Colombo","year":"1993","journal-title":"Acta Paediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib202","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199502233320803","article-title":"The risk of cancer among patients with cystic fibrosis: Cystic Fibrosis and Cancer Study Group","volume":"332","author":"Neglia","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib203","first-page":"9","article-title":"Abdominal pain in cystic fibrosis","volume":"88","author":"Littlewood","year":"1995","journal-title":"J R Soc Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib204","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/014107689809100103","article-title":"Prevalence and mechanisms of gastro-oesophageal reflux in adult cystic fibrosis patients","volume":"91","author":"Ledson","year":"1998","journal-title":"J R Soc Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib205","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0025-7125(05)70245-5","article-title":"Cystic fibrosis mutations and genetic predisposition to idiopathic chronic pancreatitis","volume":"84","author":"Cohn","year":"2000","journal-title":"Med Clin North Am"},{"key":"10.1378\/chest.125.1_suppl.1S_bib206","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0022-3468(90)90186-D","article-title":"The spectrum of appendiceal disease in cystic fibrosis","volume":"25","author":"Coughlin","year":"1990","journal-title":"J Pediatr Surg"},{"key":"10.1378\/chest.125.1_suppl.1S_bib207","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/adc.66.3.307","article-title":"Appendicitis in cystic fibrosis","volume":"66","author":"Shields","year":"1991","journal-title":"Arch Dis Child"},{"key":"10.1378\/chest.125.1_suppl.1S_bib208","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0002-9343(79)90491-1","article-title":"Cystic fibrosis in adults: 75 cases and a review of 232 cases in the literature","volume":"66","author":"di Sant'agnese","year":"1979","journal-title":"Am J Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib209","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/infdis\/148.1.176","article-title":"Isolation rate and toxigenic potential ofClostridium difficileisolates from patients with cystic fibrosis","volume":"148","author":"Wu","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1378\/chest.125.1_suppl.1S_bib210","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2214\/ajr.172.2.9930816","article-title":"Atypical presentation ofClostridium difficilecolitis in patients with cystic fibrosis","volume":"172","author":"Binkovitz","year":"1999","journal-title":"AJR Am J Roentgenol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib211","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1136\/jcp.39.9.1013","article-title":"Asymptomatic carriage ofClostridium difficilein patients with cystic fibrosis","volume":"39","author":"Peach","year":"1986","journal-title":"J Clin Pathol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib212","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1155\/2001\/745361","article-title":"Colonic disorders in adult cystic fibrosis","volume":"15","author":"Chaun","year":"2001","journal-title":"Can J Gastroenterol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib213","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1572-0241.1998.00355.x","article-title":"First adult patient with fibrosing colonopathy","volume":"93","author":"Hausler","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib214","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/BF02087437","article-title":"Crohn's disease and cystic fibrosis","volume":"39","author":"Lloyd-Still","year":"1994","journal-title":"Dig Dis Sci"},{"key":"10.1378\/chest.125.1_suppl.1S_bib215","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1155\/1996\/372704","article-title":"Colonic carcinoma in two adult cystic fibrosis patients","volume":"10","author":"Chaun","year":"1996","journal-title":"Can J Gastroenterol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib216","first-page":"153","article-title":"Meconium ileus equivalent in children and adults","volume":"89","author":"Khoshoo","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib217","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/oxfordjournals.bmb.a072581","article-title":"Cystic fibrosis: gastrointestinal complications","volume":"48","author":"Littlewood","year":"1992","journal-title":"Br Med Bull"},{"key":"10.1378\/chest.125.1_suppl.1S_bib218","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0016-5085(81)80027-3","article-title":"Gastrointestinal manifestations of cystic fibrosis: a review","volume":"81","author":"Park","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1378\/chest.125.1_suppl.1S_bib219","first-page":"299","article-title":"Incidence of distal intestinal obstruction syndrome in cystic fibrosis","volume":"2","author":"Rosenstein","year":"1983","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib220","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/adc.61.11.1128","article-title":"Gastrografin in acute meconium ileus equivalent","volume":"61","author":"O'Halloran","year":"1986","journal-title":"Arch Dis Child"},{"key":"10.1378\/chest.125.1_suppl.1S_bib221","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0022-3476(67)80019-2","article-title":"Oral administration of n-acetyl cysteine in the prophylaxis of \u201cmeconium ileus equivalent.\u201d","volume":"71","author":"Lillibridge","year":"1967","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib222","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0140-6736(86)91894-5","article-title":"Treatment of distal intestinal obstruction syndrome in cystic fibrosis with a balanced intestinal lavage solution","volume":"1","author":"Cleghorn","year":"1986","journal-title":"Lancet"},{"key":"10.1378\/chest.125.1_suppl.1S_bib223","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1542\/peds.83.5.727","article-title":"Lavage treatment of distal intestinal obstruction syndrome in children with cystic fibrosis","volume":"83","author":"Koletzko","year":"1989","journal-title":"Pediatrics"},{"key":"10.1378\/chest.125.1_suppl.1S_bib224","first-page":"149","article-title":"Meconium ileus equivalent: treatment with Hypaque enema","volume":"49","author":"Glick","year":"1980","journal-title":"Diagn Imaging"},{"key":"10.1378\/chest.125.1_suppl.1S_bib225","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0022-3476(05)83350-5","article-title":"Effects of cisapride in patients with cystic fibrosis and distal intestinal obstruction syndrome","volume":"117","author":"Koletzko","year":"1990","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib226","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/bjc.1993.474","article-title":"A cohort study of cystic fibrosis and malignancy","volume":"68","author":"Sheldon","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1378\/chest.125.1_suppl.1S_bib227","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0140-6736(83)91754-3","article-title":"Coeliac disease and malignancy","volume":"1","author":"Swinson","year":"1983","journal-title":"Lancet"},{"key":"10.1378\/chest.125.1_suppl.1S_bib228","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nm0596-593","article-title":"Cystic fibrosis hetero- and homozygosity is associated with inhibition of breast cancer growth","volume":"2","author":"Abraham","year":"1996","journal-title":"Nat Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib229","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/(SICI)1097-0215(19981023)79:5<487::AID-IJC7>3.0.CO;2-X","article-title":"CFTR \u0394F508 carrier status, risk of breast cancer before the age of 40 and histological grading in a population-based case-control study","volume":"79","author":"Southey","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1378\/chest.125.1_suppl.1S_bib230","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/jnci\/89.19.1440","article-title":"Fecal occult blood screening in the Minnesota study: sensitivity of the screening test","volume":"89","author":"Church","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1378\/chest.125.1_suppl.1S_bib231","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/jama.280.2.117","article-title":"Detection of prostate and colon cancer","volume":"280","author":"Stern","year":"1998","journal-title":"JAMA"},{"key":"10.1378\/chest.125.1_suppl.1S_bib232","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1542\/peds.98.6.1203","article-title":"Transition of care provided for adolescents with special health care needs","volume":"98","author":"American Academy of Pediatrics Committee on Children with Disabilities and Committee on Adolescence","year":"1996","journal-title":"Pediatrics"},{"key":"10.1378\/chest.125.1_suppl.1S_bib233","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/1054-139X(93)90143-D","article-title":"Transition from child-centered to adult health care systems for adolescents with chronic conditions: a position paper of the society for adolescent medicine","volume":"14","author":"Blum","year":"1993","journal-title":"J Adolesc Health"},{"key":"10.1378\/chest.125.1_suppl.1S_bib234","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/1054-139X(95)00073-2","article-title":"Transition to adult health care: setting the stage: Conference proceedings of \u201cMoving on: transition from pediatric to adult health care\u201d 9-9-94","volume":"17","author":"Blum","year":"1995","journal-title":"J Adolesc Health"},{"key":"10.1378\/chest.125.1_suppl.1S_bib235","series-title":"Surgeon general's conference: growing up and getting medical care; youth with special health care needs\u2014a summary of conference proceedings","year":"1989"},{"key":"10.1378\/chest.125.1_suppl.1S_bib236","series-title":"Transitions in care for young adults with special health needs: proceedings of a regional conference","author":"University of Washington, Division of Adolescent Medicine, Department of Pediatrics, Child Development and Mental Retardation Center","year":"1992"},{"issue":"suppl","key":"10.1378\/chest.125.1_suppl.1S_bib237","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1002\/1097-0142(19930515)71:10+<3411::AID-CNCR2820711746>3.0.CO;2-E","article-title":"Transition to adult health care for adolescents and young adults with cancer","volume":"71","author":"Rosen","year":"1993","journal-title":"Cancer"},{"issue":"Suppl 10","key":"10.1378\/chest.125.1_suppl.1S_bib238","first-page":"291","article-title":"Evaluation of patient satisfaction with the transition from a pediatric hospital to an adult centre [abstract]","author":"Abdale","year":"1994","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib239","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/1054-139X(92)90063-H","article-title":"Transition program from pediatric to adult care for cystic fibrosis patients","volume":"13","author":"Nasr","year":"1992","journal-title":"J Adolesc Health"},{"key":"10.1378\/chest.125.1_suppl.1S_bib240","unstructured":"Southern KW, Prescott JH, Conway SP, et al. Transfer of care from a pediatric to an adult cystic fibrosis unit [abstract]. European Working Group for Cystic Fibrosis, 19th European CF Conference, Paris France, 1994; Final programme & abstracts: 160"},{"issue":"Suppl 17","key":"10.1378\/chest.125.1_suppl.1S_bib241","first-page":"393","article-title":"Patient's perceptions of the transition from pediatric to adult care","author":"Townshend","year":"1998","journal-title":"Pediatr Pulmonol"},{"issue":"Suppl 13","key":"10.1378\/chest.125.1_suppl.1S_bib242","first-page":"338","article-title":"Pediatric-to-adult care transition program: the Milan experience [abstract]","author":"Nobili","year":"1996","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib243","unstructured":"O'Loane M, Joy L. The impact of cystic fibrosis patients' transition from pediatric to adult care [abstract]: 11ThInternational CF Congress, Dublin, Ireland; 1992; Final programme and abstracts: 3"},{"key":"10.1378\/chest.125.1_suppl.1S_bib244","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0025-7125(16)30505-3","article-title":"Life beyond pediatrics: transition of chronically ill adolescents from pediatric to adult health care systems","volume":"74","author":"Schidlow","year":"1990","journal-title":"Med Clin North Am"},{"key":"10.1378\/chest.125.1_suppl.1S_bib245","first-page":"241","article-title":"Transition from pediatric to adult-oriented health care for the adolescent with chronic illness or disability","volume":"5","author":"Rosen","year":"1994","journal-title":"Adolesc Health"},{"key":"10.1378\/chest.125.1_suppl.1S_bib246","series-title":"The coming of age project: a study of the transition from paediatric to adult care and treatment adherence amongst young people with cystic fibrosis; summary report","author":"Pownceby","year":"1996"},{"key":"10.1378\/chest.125.1_suppl.1S_bib247","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1207\/s15326888chc1804_4","article-title":"Assessment of readiness to transfer to adult care for adolescents with cystic fibrosis","volume":"18","author":"Cappelli","year":"1989","journal-title":"Child Health Care"},{"issue":"Suppl 9","key":"10.1378\/chest.125.1_suppl.1S_bib248","first-page":"291","article-title":"Making the change: a transition packet for teens and adults with cystic fibrosis (CF) [abstract]","author":"Zanker","year":"1993","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib249","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1056\/NEJM196807112790203","article-title":"Reproductive failure in males with cystic fibrosis","volume":"279","author":"Kaplan","year":"1968","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib250","first-page":"152","article-title":"Reproductive defects in patients of both sexes with cystic fibrosis: a review","volume":"15","author":"Seale","year":"1985","journal-title":"Ann Clin Lab Sci"},{"key":"10.1378\/chest.125.1_suppl.1S_bib251","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0272-5231(21)01130-8","article-title":"Fertility and pregnancy in patients with cystic fibrosis","volume":"13","author":"Kotloff","year":"1992","journal-title":"Clin Chest Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib252","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1164\/ajrccm.153.2.8564145","article-title":"Cystic fibrosis 3849+10kb C > T mutation associated with severe pulmonary disease and male fertility","volume":"153","author":"Dreyfus","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib253","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0002-9378(70)90254-1","article-title":"Cervical mucus in cystic fibrosis: a possible cause of infertility","volume":"108","author":"Oppenheimer","year":"1970","journal-title":"Am J Obstet Gynecol"},{"issue":"suppl","key":"10.1378\/chest.125.1_suppl.1S_bib254","first-page":"36","article-title":"Cystic fibrosis and pregnancy","volume":"85","author":"Geddes","year":"1992","journal-title":"J R Soc Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib255","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0015-0282(16)39790-4","article-title":"Water and electrolytes in cervical mucus from patients with cystic fibrosis","volume":"24","author":"Kopito","year":"1973","journal-title":"Fertil Steril"},{"key":"10.1378\/chest.125.1_suppl.1S_bib256","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1378\/chest.86.6.863","article-title":"Use of oral contraceptives in women with cystic fibrosis","volume":"86","author":"Fitzpatrick","year":"1984","journal-title":"Chest"},{"key":"10.1378\/chest.125.1_suppl.1S_bib257","first-page":"408","article-title":"Influence of panel-reactive antibody on survival and rejection after lung transplantation","volume":"16","author":"Gammie","year":"1997","journal-title":"J Heart Lung Transplant"},{"key":"10.1378\/chest.125.1_suppl.1S_bib258","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0015-0282(16)56754-5","article-title":"Microsurgical epididymal sperm aspiration and intracytoplasmic sperm injection: a new effective approach to infertility as a result of congenital bilateral absence of the vas deferens","volume":"61","author":"Tournaye","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1378\/chest.125.1_suppl.1S_bib259","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0022-5347(17)35225-4","article-title":"Results in the United States with sperm microaspiration retrieval techniques and assisted reproductive technologies","volume":"151","author":"The Sperm Microaspiration Retrieval Techniques Study Group","year":"1994","journal-title":"J Urol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib260","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1378\/chest.118.4.1059","article-title":"Fertility in men with cystic fibrosis: an update on current surgical practices and outcomes","volume":"118","author":"McCallum","year":"2000","journal-title":"Chest"},{"key":"10.1378\/chest.125.1_suppl.1S_bib261","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0140-6736(80)90183-X","article-title":"Cystic fibrosis and pregnancy: a national survey","volume":"2","author":"Cohen","year":"1980","journal-title":"Lancet"},{"key":"10.1378\/chest.125.1_suppl.1S_bib262","doi-asserted-by":"crossref","first-page":"596","DOI":"10.7326\/0003-4819-99-5-596","article-title":"Pregnancy in patients with cystic fibrosis","volume":"99","author":"Palmer","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib263","first-page":"391","article-title":"Respiratory diseases in pregnancy","volume":"5","author":"Noble","year":"1988","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1378\/chest.125.1_suppl.1S_bib264","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0272-5231(21)01125-4","article-title":"Respiratory physiology in pregnancy","volume":"13","author":"Elkus","year":"1992","journal-title":"Clin Chest Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib265","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/ajcn\/49.4.612","article-title":"Breast-milk composition in women with cystic fibrosis: report of two cases and a review of the literature","volume":"49","author":"Shiffman","year":"1989","journal-title":"Am J Clin Nutr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib266","series-title":"Recommended dietary allowances","author":"Food and Nutrition Board and National Research Council","year":"1974"},{"key":"10.1378\/chest.125.1_suppl.1S_bib267","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0022-3476(94)70194-6","article-title":"Kyphosis and fractures in children and young adults with cystic fibrosis","volume":"125","author":"Henderson","year":"1994","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib268","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-128-3-199802010-00004","article-title":"Increased rate of fracture and severe kyphosis: sequelae of living into adulthood with cystic fibrosis","volume":"128","author":"Aris","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib269","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1378\/chest.109.5.1176","article-title":"Severe osteoporosis before and after lung transplantation","volume":"109","author":"Aris","year":"1996","journal-title":"Chest"},{"key":"10.1378\/chest.125.1_suppl.1S_bib270","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0002-9343(96)00155-6","article-title":"Osteoporosis in lung transplantation candidates with end-stage pulmonary disease","volume":"101","author":"Shane","year":"1996","journal-title":"Am J Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib271","first-page":"1313","article-title":"Back pain and spinal deformity in cystic fibrosis","volume":"141","author":"Rose","year":"1987","journal-title":"Am J Dis Child"},{"key":"10.1378\/chest.125.1_suppl.1S_bib272","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0022-3476(88)80268-3","article-title":"Osteoporosis in cystic fibrosis","volume":"113","author":"Gibbens","year":"1988","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib273","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0002-9343(94)90112-0","article-title":"Osteopenia in adults with cystic fibrosis","volume":"96","author":"Bachrach","year":"1994","journal-title":"Am J Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib274","first-page":"589","article-title":"Bone mineral density and body composition in adults with cystic fibrosis","volume":"48","author":"Grey","year":"1993","journal-title":"Thoracic"},{"key":"10.1378\/chest.125.1_suppl.1S_bib275","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1164\/ajrccm.157.6.9712089","article-title":"Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease","volume":"157","author":"Donovan","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib276","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/thx.43.3.190","article-title":"Vitamin D and parathyroid hormone and bone mineralization in adults with CF","volume":"43","author":"Stead","year":"1988","journal-title":"Thorax"},{"key":"10.1378\/chest.125.1_suppl.1S_bib277","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/archpedi.1979.02130060072016","article-title":"Demineralization in cystic fibrosis","volume":"133","author":"Mischler","year":"1979","journal-title":"Am J Dis Child"},{"key":"10.1378\/chest.125.1_suppl.1S_bib278","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0022-3476(96)70424-9","article-title":"Bone density in children and adolescents with cystic fibrosis","volume":"128","author":"Henderson","year":"1996","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib279","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0022-3476(79)80346-7","article-title":"Reduced serum 25 hydroxy vitamin D con-centration and disordered mineral metabolism in patients with cystic fibrosis","volume":"94","author":"Hahn","year":"1979","journal-title":"J Pediatr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib280","first-page":"103","article-title":"Correlates of osteopenia in patients with cystic fibrosis","volume":"97","author":"Bhudhikanok","year":"1996","journal-title":"Pediatrics"},{"key":"10.1378\/chest.125.1_suppl.1S_bib281","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1203\/00006450-199703000-00016","article-title":"Bone demineralization in CF: evidence of imbalance between bone formation and degradation","volume":"41","author":"Baroncelli","year":"1997","journal-title":"Pediatr Res"},{"key":"10.1378\/chest.125.1_suppl.1S_bib282","first-page":"377","article-title":"Hypovitaminosis D and response to supplementation in older patients with cystic fibrosis","volume":"219","author":"Hanly","year":"1985","journal-title":"Q J Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib283","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/thx.54.11.961","article-title":"Low bone mineral density in adults with cystic fibrosis","volume":"54","author":"Haworth","year":"1999","journal-title":"Thorax"},{"key":"10.1378\/chest.125.1_suppl.1S_bib284","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s001980050202","article-title":"Altered calcium homeostasis in adults with cystic fibrosis","volume":"10","author":"Aris","year":"1999","journal-title":"Osteoporos Int"},{"key":"10.1378\/chest.125.1_suppl.1S_bib285","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1164\/ajrccm.162.3.9910118","article-title":"Bone density, body composition and inflammatory status in cystic fibrosis","volume":"162","author":"Ionescu","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib286","doi-asserted-by":"crossref","first-page":"516","DOI":"10.7326\/0003-4819-112-7-516","article-title":"Screening for osteoporosis","volume":"112","author":"Melton","year":"1990","journal-title":"Ann Int Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib287","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","article-title":"The diagnosis of osteoporosis","volume":"9","author":"Kanis","year":"1994","journal-title":"J Bone Miner Res"},{"key":"10.1378\/chest.125.1_suppl.1S_bib288","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/ajcn\/73.3.602","article-title":"Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients","volume":"73","author":"Lark","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"10.1378\/chest.125.1_suppl.1S_bib289","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/thorax.56.4.314","article-title":"Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis","volume":"56","author":"Haworth","year":"2001","journal-title":"Thorax"},{"key":"10.1378\/chest.125.1_suppl.1S_bib290","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1164\/ajrccm.162.3.2002051","article-title":"Efficacy of pamidronate for osteoporosis in cystic fibrosis patients following lung transplantation","volume":"162","author":"Aris","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib291","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/rheumatology\/27.5.339","article-title":"Cystic fibrosis, chronic bacterial infection and rheumatic disease","volume":"27","author":"Bresnihan","year":"1988","journal-title":"Br J Rheumatol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib292","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/adc.59.4.377","article-title":"Arthritis in cystic fibrosis","volume":"59","author":"Schidlow","year":"1984","journal-title":"Arch Dis Child"},{"key":"10.1378\/chest.125.1_suppl.1S_bib293","first-page":"651","article-title":"Episodic arthropathy in adult cystic fibrosis","volume":"64","author":"Bourke","year":"1987","journal-title":"Q J Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib294","series-title":"Cystic fibrosis in adults","first-page":"439","article-title":"Rheumatic disease in cystic fibrosis","author":"Noone","year":"1999"},{"key":"10.1378\/chest.125.1_suppl.1S_bib295","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/bmj.288.6420.822","article-title":"Hypertrophic osteoarthropathy in cystic fibrosis","volume":"288","author":"Braude","year":"1984","journal-title":"BMJ"},{"key":"10.1378\/chest.125.1_suppl.1S_bib296","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/archpedi.1986.02140150076042","article-title":"Evaluation of pulmonary hypertrophic osteoarthropathy in cystic fibrosis: a comprehensive study","volume":"140","author":"Cohen","year":"1986","journal-title":"Am J Dis Chest"},{"key":"10.1378\/chest.125.1_suppl.1S_bib297","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00241837","article-title":"Bone changes associated with cystic fibrosis","volume":"21","author":"Lipnick","year":"1992","journal-title":"Skeletal Radiol"},{"key":"10.1378\/chest.125.1_suppl.1S_bib298","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1542\/peds.100.2.205","article-title":"End-of-life care in cystic fibrosis","volume":"100","author":"Robinson","year":"1997","journal-title":"Pediatrics"},{"key":"10.1378\/chest.125.1_suppl.1S_bib299","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00063198-199811000-00004","article-title":"End-of-life care in cystic fibrosis","volume":"4","author":"Tonelli","year":"1998","journal-title":"Curr Opin Pulm Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib300","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJM199204303261804","article-title":"Prediction of mortality in patients with cystic fibrosis","volume":"326","author":"Kerem","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib301","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1378\/chest.113.5.1230","article-title":"Risk of death in cystic fibrosis patients with severely compromised lung function","volume":"113","author":"Milla","year":"1998","journal-title":"Chest"},{"key":"10.1378\/chest.125.1_suppl.1S_bib302","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1378\/chest.115.3.782","article-title":"Timing of referral for lung transplantation for cystic fibrosis: overemphasis on FEV1may adversely affect overall survival","volume":"115","author":"Doershuk","year":"1999","journal-title":"Chest"},{"key":"10.1378\/chest.125.1_suppl.1S_bib303","author":"The EPEC (Education for Physicians on End-of-Life Care) Project"},{"key":"10.1378\/chest.125.1_suppl.1S_bib304","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1542\/peds.98.4.741","article-title":"Chronic pain in cystic fibrosis","volume":"98","author":"Ravilly","year":"1996","journal-title":"Pediatrics"},{"key":"10.1378\/chest.125.1_suppl.1S_bib305","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1164\/ajrccm.159.1.ats898","article-title":"Dyspnea: mechanisms, assessment, and management; a consensus statement","volume":"159","author":"American Thoracic Society","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib306","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/jama.285.10.1331","article-title":"Perspectives on care at the close of life: management of dyspnea in patients with far-advanced lung disease; \u201conce I lose it, it's kind of hard to catch it.\u201d","volume":"285","author":"Luce","year":"2001","journal-title":"JAMA"},{"key":"10.1378\/chest.125.1_suppl.1S_bib307","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1001\/jama.1978.03280450023017","article-title":"Assisted ventilation for patients with cystic fibrosis","volume":"239","author":"Davis","year":"1978","journal-title":"JAMA"},{"key":"10.1378\/chest.125.1_suppl.1S_bib308","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1183\/09031936.97.10091999","article-title":"Nocturnal ventilatory support in patients with cystic fibrosis: comparison with supplemental oxygen","volume":"10","author":"Gozal","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.125.1_suppl.1S_bib309","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1183\/09031936.93.04050524","article-title":"Non-invasive mechanical ventilation for cystic fibrosis patients: a potential bridge to transplantation","volume":"4","author":"Hodson","year":"1991","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.125.1_suppl.1S_bib310","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1164\/ajrccm.163.1.2005130","article-title":"Low-flow oxygen and bilevel ventilatory support: effects on ventilation during sleep in cystic fibrosis","volume":"163","author":"Milross","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib311","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1164\/ajrccm.163.2.2003076","article-title":"Outcomes of intensive care unit care in adults with cystic fibrosis","volume":"163","author":"Sood","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib312","unstructured":"The US Organ Procurement and Transplantation Network and The Scientific Registry of Transplant Recipients. 2001 annual report of the US Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: transplant data 1991\u20132000. Department of Health and Human Services, Health Resources and Services Administration, Office of Special Programs, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; and University Renal Research and Education Association, Ann Arbor, MI"},{"key":"10.1378\/chest.125.1_suppl.1S_bib313","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1016\/S0041-1345(01)02423-X","article-title":"Living donor lung transplantation: selection, technique, and outcome","volume":"33","author":"Barr","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1378\/chest.125.1_suppl.1S_bib314","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00063198-199911000-00008","article-title":"Lung transplantation for cystic fibrosis: an update and practical considerations for referring candidates","volume":"5","author":"Shapiro","year":"1999","journal-title":"Curr Opin Pulm Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib315","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1164\/ajrccm.158.1.15812","article-title":"International guidelines for the selection of lung transplant candidates","volume":"158","author":"Maurer","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.125.1_suppl.1S_bib316","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1378\/chest.113.1.217","article-title":"Lung transplantation in cystic fibrosis: consensus conference statement","volume":"113","author":"Yankaskas","year":"1998","journal-title":"Chest"},{"key":"10.1378\/chest.125.1_suppl.1S_bib317","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1001\/jama.286.21.2683","article-title":"Survival effect of lung transplantation for patients with cystic fibrosis","volume":"286","author":"Liou","year":"2001","journal-title":"JAMA"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215322182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215322182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:43:45Z","timestamp":1757918625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215322182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":317,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0012369215322182"],"URL":"https:\/\/doi.org\/10.1378\/chest.125.1_suppl.1s","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cystic Fibrosis Adult Care","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.125.1_suppl.1S","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}